Industry update Canadian pot production slows as supply eases to 1.1B grams Around 96,000 kg of dried bud was produced last December, an 11-month low, as cultivators grapple with supply issues Jared GnamApril 26, 2021
News US appeals court rejects Harborside bid to end 280E Court ruling means US weed operators will continue to pay higher taxes than federally legal businesses Jared GnamApril 23, 2021
News MindMed stock surges on Nasdaq listing approval After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company Jared GnamApril 23, 2021
News Canopy links up with major US alcohol distributor Canadian weed titan inks deal with Southern Glazer's to sell its Quatreau CBD drinks across America Jared GnamApril 21, 2021
Industry update Weed use up 43% since legalization: StatsCan But it's too early to peg the increase on Covid-19, agency says Jared GnamApril 21, 2021
Canada Health Canada opens up CBD market with new hemp cultivar approvals With around a dozen new high-CBD hemp varieties approved, companies eye low-cost production and looser cannabidiol rules Jared GnamApril 21, 2021
Industry update NORML calls on US pot activists this 4/20 to ‘finish the fight’ Long-time advocacy group wants US stoners to urge federal and state lawmakers to legalize on weed culture's big day Jared GnamApril 19, 2021
Industry update US House will vote on cannabis banking bill next week House Majority Leader Steny Hoyer has added the SAFE Banking Act to next week's legislative calendar Jared GnamApril 16, 2021
Industry update Tilray reduces required shareholder vote count to 1/3 for Aphria merger The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30 Jared GnamApril 16, 2021
Industry update Attend next week’s psychedelics legalization debate Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform Nick LabaApril 16, 2021